Skip NavigationSkip to Content
Return Return to Search Results

Structure-activity relationship studies and in vitro and in vivo anticancer activity of novel 3-aroyl-1,4-diarylpyrroles against solid tumors and hematological malignancies

  1. Author:
    Puxeddu, Michela
    Shen, Hongliang
    Bai,Ruoli
    Coluccia, Antonio
    Nalli, Marianna
    Mazzoccoli, Carmela
    Da Pozzo, Eleonora
    Cavallini, Chiara
    Martini, Claudia
    Orlando, Viviana
    Biagioni, Stefano
    Mazzoni, Cristina
    Coluccia, Addolorata Maria Luce
    Hamel,Ernest
    Liu, Te
    Silvestri, Romano
    La Regina, Giuseppe

  2. Author Address

    Laboratory Affiliated with the Institute Pasteur Italy - Cenci Bolognetti Foundation, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185, Roma, Italy. Electronic address: michela.puxeddu@uniroma1.it., Department of Urology, Capital Medical University Beijing Friendship Hospital, Beijing, 100050, China. Electronic address: 1051486940@qq.com., Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, United States., Laboratorio di Ricerca Pre-Clinica e Traslazionale, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Centro di Riferimento Oncologico della Basilicata, Via Padre Pio 1, I-85028, Rionero in Vulture, Italy., Department of Pharmacy, University of Pisa, Via Bonanno Pisano 6, I-56126, Pisa, Italy., Department of Biology and Biotechnologies "Charles Darwin", Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185, Roma, Italy., Department of Biological and Environmental Sciences and Technologies, University of Salento, I-73100, Lecce, Italy., Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 365 South Xiangyang Road, Shanghai, 200031, China. Electronic address: 0721160004@mail.tongji.edu.cn., Laboratory Affiliated with the Institute Pasteur Italy - Cenci Bolognetti Foundation, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185, Roma, Italy. Electronic address: romano.silvestri@uniroma1.it., Laboratory Affiliated with the Institute Pasteur Italy - Cenci Bolognetti Foundation, Department of Drug Chemistry and Technologies, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185, Roma, Italy. Electronic address: giuseppe.laregina@uniroma1.it.,
    1. Year: 2020
    2. Date: Jan 1
    3. Epub Date: 2019 11 02
  2. Journal: European journal of medicinal chemistry
    1. 185
    2. Pages: 111828
  4. Type of Article: Article
  5. Article Number: 111828
  6. ISSN: 0223-5234
  1. Abstract:

    Novel 3-aroyl-1,4-diarylpyrrole derivatives were synthesized to explore structure-activity relationships at the phenyls at positions 1 and 4 of the pyrrole. The presence of amino phenyl rings at positions 1 and 4 of the pyrrole ring were found to be a crucial requirement for potent antitumor activity. Several compounds strongly inhibited tubulin assembly through binding to the colchicine site. Compounds 42, 44, 48, 62 and 69 showed antitumor activity with low nanomolar IC50 values in several cancer cell lines. Compound 48 was generally more effective as an inhibitor of glioblastoma, colorectal and urinary bladder cancer cell lines; 69 consistently inhibited CML cell lines and demonstrated superiority in nilotinib and imatinib resistant LAMA84-R and KBM5-T315I cells. In animal models, compound 48 exhibited significant inhibition of the growth of T24 bladder carcinoma and ES-2 ovarian clear cell carcinoma tumors. Compounds 48 and 69 represent robust lead compounds for the design of new broad-spectrum anticancer agents active in different types of solid and hematological tumors. Copyright © 2019 Elsevier Masson SAS. All rights reserved.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.ejmech.2019.111828
  3. PMID: 31727471
  4. View record in Web of Science®
  5. WOS: 000503099900046
  6. PII : S0223-5234(19)30980-8

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel